VEGFR3/FLT4 Polyklonaler Antikörper

VEGFR3/FLT4 Polyklonal Antikörper für WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, IF, ELISA

Konjugation

Unkonjugiert

Publikationen(17)

Kat-Nr. : 20712-1-AP

Synonyme

FLT4, Fms like tyrosine kinase 4, FLT41, FLT-4, FLT 4



Geprüfte Anwendungen

Erfolgreiche Detektion in WBMausmilzgewebe, HeLa-Zellen, Mausherzgewebe, PC-3-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:200-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

20712-1-AP bindet in WB, IHC, IF, ELISA VEGFR3/FLT4 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen Peptid
Vollständiger Name fms-related tyrosine kinase 4
Berechnetes Molekulargewicht 153 kDa
Beobachtetes Molekulargewicht 125 kDa
GenBank-ZugangsnummerNM_002020
Gene symbol FLT4
Gene ID (NCBI) 2324
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

FLT4, also named VEGFR-3, belongs to the protein kinase superfamily, Tyr protein kinase family, and CSF-1/PDGF receptor subfamily. It is a receptor for VEGFC. FLT4 has a tyrosine-protein kinase activity. Defects in FLT4 cause lymphedema hereditary type 1 (LYH1A). Defects in FLT4 are found in juvenile hemangioma. VEGFR-3 is a highly glycosylated protein and migrates as bands with different molecular weights: an ~175 kDa precursor, an ~195 kDa mature form, an ~140 kDa non-glycosylated backbone, and a form that appears to be partially cleaved proteolytically in the extracellular domain to produce an ~125 kDa band(PMID: 15389531).

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for VEGFR3/FLT4 antibody 20712-1-APProtokoll herunterladen
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanIF

Mol Cancer

m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma

Authors - Han Fang
humanWB

Int J Biol Sci

PROTAC-Surufatinib Suppresses Pancreatic Neuroendocrine Neoplasms Progression by Inducing Ferroptosis through Inhibiting WNT/β-catenin Pathway Mediated by HMOX1

Authors - Bingyan Xue
humanIHC

Front Oncol

The Specifically Androgen-Regulated Gene (SARG) Promotes Papillary Thyroid Carcinoma (PTC) Lymphatic Metastasis Through Vascular Endothelial Growth Factor C (VEGF-C) and VEGF Receptor 3 (VEGFR-3) Axis.

Authors - Shuai-Jun Xu
DeerWB

Stem Cell Res Ther

Deer thymosin beta 10 functions as a novel factor for angiogenesis and chondrogenesis during antler growth and regeneration.

Authors - Wei Zhang
humanWB

Pharmaceuticals (Basel)

Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells.

Authors - Nada Amri
humanWB

Mol Cell Endocrinol

Long noncoding RNA GAS5 accelerates diabetic wound healing and promotes lymphangiogenesis via miR-217/Prox1 axis.

Authors - Zhi-You He

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


FH

Shinford (Verified Customer) (12-15-2023)

We used the concentration of 1:500 to get a very strong band. It is a big volume set.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:500
  • Cell Tissue Type: Lung cancer cell lines, lung cancer tissues
VEGFR3/FLT4 Antibody Western Blot validation (1:500 dilution) in Lung cancer cell lines, lung cancer tissues (Cat no:20712-1-AP)